Истраживачи
Popović, Đorđe
| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
|---|---|---|---|---|
| 2021 | Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World Study (✓) | Velojic-Golubovic, Milena D   ; Ciric, Vojislav M ; Dimitrijevic, Marija V; Kovic, Tijana; Mitic, Milica; Olujic, Biljana; Pevac, Natasa; Radenkovic, Sasa P ; Radojkovic, Danijela B ; Vukadinovic, Selena;
Popovic, Djordje S
; | Научни чланак | 22M22 - Рад у истакнутом међ. часопису |
| 2021 | The new dual gastric inhibitory peptide/glucagon-like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright? | Papachristou, Stella; Popovic, Djordje S ; Papanas, Nikolaos | Научни чланак | 21M21 - Рад у врхунском међ. часопису |
| 2021 | Beta-Catenin Signaling Pathway: Perhaps We Should Start Exploring it for Diabetic Foot Ulcer Healing? | Papanas, Nikolaos; Popovic, Djordje S | Научни чланак | 23M23 - Рад у међ. часопису |
| 2021 | Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review (✓) | Popovic, Djordje S ; Papanas, Nikolaos; Pantea-Stoian, Anca; Rizvi, Ali A; Janez, Andrej; Rizzo, Manfredi | Научни чланак | 22M22 - Рад у истакнутом међ. часопису |
| 2021 | One-hour Post-load Plasma Glucose Cut-off Value for Diagnosing Diabetes: Do the New Data Bring us Closer to the Answer? | Popovic, Djordje S ; Papanas, Nikolaos | Информативни прилог | 23M23 - Рад у међ. часопису |
| 2021 | New Sub-Phenotyping of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications? | Popovic, Djordje S ; Rizzo, Manfredi; Stokic, Edita J; Papanas, Nikolaos | Научни чланак | 22M22 - Рад у истакнутом међ. часопису |